Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Belgium Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20102
20111
20132
20163
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Amgen1
Debiopharm International SA1
Gustave Roussy, Cancer Campus, Grand Paris1
Janssen Research & Development, LLC1
Kite, A Gilead Company1
Lymphoma Study Association1
Merus B.V.1
Millennium Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell15
Lymphoma5
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Neoplasms2
Recurrence2
Breast Neoplasms1
Burkitt Lymphoma1
Febrile Neutropenia1
Leukemia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.